China Resources Shuanghe announced that the company previously introduced lomustine capsules and submitted a marketing license application to the State Drug Administration on January 31, 2024. Recently, the drug obtained a drug registration certificate and was approved for marketing by the State Drug Administration on August 25, 2026, and also obtained a 6-year data protection period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.